Bob Masterson, President and CEO of The Chemistry Industry Association of Canada
The IARC Monographs Program has been plagued by transparency issues and conflicts of interest
The IARC and the flawed carcinogenic classifications of its tarnished Monographs Program are influencing policy again
The House Science, Space and Technology Committee held a full committee hearing on Feb. 6
The EU voted last November to renew the license of glyphosate for another five years
the number of agents the International Agency for Research (IARC) on Cancer has now researched before finding one substance that was “probably not” likely to cause cancer in humans.